NeuroPace
Mountain View
About NeuroPace
NeuroPace designs develops, manufactures, and markets implantable devices for the treatment of neurological disorders. It offers a responsive Neurostimulator system (RNS) for the treatment of medically refractory partial epilepsy. The company's RNS system consists of implantable components, including RNS neurostimulator that delivers a short train of electrical pulses to the brain, and depth leads and cortical strip leads; and external products, such as the programmer, a laptop computer with proprietary software that has a wand and telemetry interface enabling communication with an implanted RNS neurostimulator. NeuroPace was incorporated in 1997 and is based in Mountain View, California.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Estimated revenue: $50K – $100K
- Total funding: $457.1M
- Funding stage: IPO
- Last round: Post-IPO Debt (Jun 2025)
- Ticker: nasdaq:NPCE
- Website: neuropace.com
- Phone: 6502372701
Industries & Categories
Health Care, Manufacturing, Medical Device, Neuroscience
Social Profiles
Canonical: https://fsome.com/organization/neuropace-1108 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.